Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > Another NR
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(32)
•••
Comment by Hideawayon Dec 21, 2021 11:54am
177 Views
Post# 34250756

RE:RE:RE:Another NR

RE:RE:RE:Another NRBiotech,looks as if your post back in Oct. was spot on.I'm anxious to get more details when they present at an upcoming conference.They did not elaborate on the date or whom was sponsoring the sessions but I hope it will not too far in future.
I agree that it is extremely encouraging that there was at least one with "complete recovery".This should spark Merck to review closely to determine their next actions.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities